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HISTORICAL ARCHIVES
Early history of uremia
GABRIEL RICHET
Paris, Fiance
Richard Bright's clinico-anatomical observation caused a
veritable medical earthquake. In contrast the concept of uremia
took many years to develop. In fact, widespread acceptance of
'uremia" did not occur until some fifty years after the chemical
discovery of urea.
The discovery of urea (1797—1827)
The important, but rather vague, observations of Boerhaave
(1668—1738) [II in Holland and the more precise ones of Rouelle
Ic Cadet (1718—1779) [21 in France suggested the presence of
large quantities of an unknown "soapy" substance in the urine.
Between 1797 and 1808, A. Fourcroy (1755—1809) and N.
Vauquelin (1763—1829) isolated and crystallized this substance,
called it "urea" and ascertained the weight of its constituent
atomic components [3—51. These individuals introduced the
concept that urea represented the end product of nitrogenous
metabolism and was a compound present in all "living tissues".
Moreover, they suggested that the principal function of the
kidney was to "dc-nitrogenize" the body by excreting urea in
the urine. Finally, they hypothesized that urea was the source
of urinary ammonia, a constituent which had been recently
discovered by C. Berthollet (1760—1822). Fourcroy and Vauquelin
unmistakably anticipated Claude Bernard's synoplic concept of
the 'Milieu Interieur' by proposing that the blood "prend et
conserve l'équilibre de composition qui lui est nécessaire"
(takes and protects its necessary balanced composition). Using
other chemical methods, i.E. Bérard [61 and W. Prout [7]
reached the same conclusion in 1817.
Turning their attention to pathophysiology. Fourcroy and
Vauquelin predicted that if urea is not "separated" from the
blood, an excess might lead to specific disorders. The two
embarked on an extensive study of the urinary excretion of urea
hoping to reveal some hitherto unidentified diseases. Their
investigations were performed in a well equiped, designated
hospital, specializing only in this research. In 1808, they ex-
panded their investigations to include chemical observations,
long term trials, and animal experiments, in effect, they were
anticipating such centers as the Institut Pasteur, the National
institutes of Health, the Royal Postgraduate Hospital, the
Karolinska and the Behring Institutes. As Peilzman [8] and
Coley [91 emphasized, a similar 'task force' was organized in
1842 in Guy's Hospital when Richard Bright's group supervised
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a two ward unit linked to a specialized laboratory which had an
emphasis on the study of diseases of the kidney. John Bostock
and G.O. Owen were directly involved as clinical chemists of
the group.
Fourcroy was a remarkable individual; he started as a phy-
sician and then became a chemist working alongside Lavoisier.
His lodestar was plain for all to see when he founded a journal
entitled "La Médecine éclairée par les Sciences Physiques", a
publication more than sixty years ahead of its time. His
dedication was exemplified by his laborious analysis of more
than 300 urinary calculi in a quest to discover a means of
dissolving these stones. in 1794, he organized a centralized
teaching program which was to encompass all forms of educa-
tion. With respect to medical training, he established three
Facultés de Médecine in which two novel ideas were instituted:
the "exact sciences" were taught, and the students were
required to visit university hospitals every day. A revolution
within the Revolution had occurred.
In 1821, in Geneva, J.L. PrCvost and J.B. Dumas (1800—1884)
reported that following a bilateral nephrectomy in many dif-
ferent animal species, a significant rise in the concentration of
blood urea occurred uniformly [10]. Confirmation that the
retained product was indeed ui-ca was obtained by demonstrat-
ing that the weight of the atomic components of the blood
extract was identical to that of urinary urea. Thus, it could be
concluded that urea was produced in the body and excreted by
the kidney. These findings were confirmed by L. Gmelin
(1788—1853) and F. Tiedemann (1781—1861).
The discoveries ofF. Wöhler(1800—l882) were next, in 1827
he was able to synthesize urea, the first organic substance
belonging to the animal kingdom to be produced in the labora-
tory [Il]. From Berlin, Wöhler wrote to the revered J.J.
Berzelius in Stockholm (1776—1848) that "I can make ui-ca
without needing a kidney, whether of man or dog. The ammo-
nium salt of cyanic acid is urea." As a result of this advance,
the previous mysterious biochemistry of urea became nothing
else than ordinary chemistry. in 1856, M. Bechamp [12] forged
the last link when he obtained urea in vitro by protein oxidation.
At this time another relevant discovery of immense impor-
tance was made by Henri Dutrochet (1776-1847), a country
practitioner, who in 1827 described his investigations on the
phenomenon of osmosis in vegetables and animals [13]. As a
resLilt of these reports, Thomas Graham (1805—1869), in 1850.
used a semipermeable membrane in vitro and was able to
separate large from small molecules. The concept of "dialysis"
was born and the seed idea for the artificial kidney had been
sown-
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Urea versus the dogmas of morbid anatomy (1827—1856)
When Fourcroy first proposed the idea that urea might be a
toxic substance, the concept was considered totally unaccept-
able. In Richard Bright's era, "morbid anatomy" was the
accepted doctrine and all other explanations for disease pro-
cesses were deemed fanciful and unworthy of consideration. A
form of "intellectual terrorism" prevailed, an attitude that has
persisted to this day. One must admit that the concept of
morbid anatomy was a successful science, delineating, within
no more than a decade, such diseases as cirrhosis of the liver,
visceral tuberculosis, general paresis, diphtheria and typhoid. It
was strictly within the constraints of this structural philosophy
that Bright made his revealing contribution. However, Fourcroy's
hypotheses were not forgotten. In France, P.H. Nysten
(1774—1817) [14] had already published a book on the subject. In
England, Prout [151 was an active participant in chemical
pathology, a difficult challenge when the methods of chemical
analysis were at best semiquantititive and existed for only a few
of the more highly concentrated plasma components. At Guy's
Hospital Bright's group [16], J. Bostock [17], G.H. Barlow [181
and O.W. Rees [19], proposed that urea might be a retained
product in kidney disease. However, R. Christison [20] and J.C.
Gregory [21], both of Edinburgh, in 1829 and 1831 respectively,
reported convincing chemical evidence that the blood urea
concentration was elevated in certain patients. They suggested
that the retention of urea might have deleterious clinical effects.
International confirmation of these findings by P. Rayer
(1793—1867) [22] and R.F. Marchand [23] soon followed the
British observations.
Confusion reigned. A semiquantitative determination of blood
urea required more than fifty milliliters of severely uremic
blood, and the poor technique did not lead to reproducible
results. This lack of reliability explains why Christison reported
that only 9 of 31 patients with "Bright's Disease" had a blood
urea determination [24]. Blood urea concentration was in-
creased in all nine patients, but there was no correlation
between the approximate urea concentration and the presence
of edema, the intensity of anemia, the plasma protein concen-
tration, the severity of proteinuria or the urine output. Further-
more, there was no relation between the blood urea concentra-
tion and the presence of acute or chronic renal disease. This
uncertainty explains the prudent reserve of the then two great
men, Bright [16] and Rayer [22]. Both men published their
observations but were reluctant to defend them openly. Never-
theless, both made the important observation that major neu-
rological disorders, such as coma and convulsions, did not
correlate with any obvious macroscopic finding, including gen-
eralized edema of the brain. This finding supported the notion of
uremia as a form of "blood poisoning". A. Wilson [251 and T.
Addison [26] lent support to this concept in their writings as
well. In 1839 Christison [241 shed light on the matter by
considering two categories of clinical findings noted in patients
with the end stage of "Bright's Disease". He denoted some
findings as "primary", or linked directly to the specific disease
affecting the kidney. Others findings, notably digestive and
neurological abnormalities, were thought to be "secondary"
effects related to renal failure and an endogenous intoxication.
With these observations, Christison paved the way for the
modern concept of the "uremic syndrome."
In the decade between 1840 and 1850, a change in the climate
of opinion occurred, despite the absence of any major chemical
advance. G. Burrows [27] had the temerity to promote the
cause of 'Humoral Pathology' n "Bright's Disease" by writing
that "morbid anatomy is the right hand of pathology; animal
chemistry is the left." He supported his argument with quota-
tions from Orfila, who brought science into the study of
toxicology in France, and from Magendie, the innovator of
experimental pharmacology. Andral [29] provocatively joined
in by pointing out that all these suggestions implied that the
composition of the blood could be altered. For the traditional
physicians there was a danger of "falling into the heresy of
Humorism." For Andral this was "an unavoidable fate if that
was the direction that the facts were taking." This sentiment
was repeated verbatim as early as 1840 in Anger's Thesis,
defended in Prague, entitled "Conspectum morbi Brighti His-
toricum," demonstrating just how rapidly new ideas circulated
in Europe. It is interesting to follow Andral's intellectual
itinerary. As he stated himself, he had studied medicine three
times: when he mastered pathological anatomy, when he
learned the new methods of physical diagnosis, and when he
started his study on hemopathology (quoted from E.H.
Ackerknecht [28]),
Although Claude Bernard was investigating the mechanisms
of clinical disease in such chemical conditions as diabetes
mellitus and carbon monoxide poisoning, there was a continu-
ing reluctance to accept the theory that renal failure might be
accompanied by a toxic humoral disorder. Even Andral [29],
who was a protagonist of 'Humoral Disorders,' failed to men-
tion what happens to urea when writing about the blood
changes that occur in dropsy. Piorry, who in 1840 [301 had
discussed among other endogenous poisonings the consequences
of "contaminating the blood with urine," did not mention the
blood urea concentration in the book in which he actually
coined the word "uremia" in 1847 [31]. Becquerel and Rodier
[32] did the same in 1854.
The next turning point was E.T. Frerichs' monograph [33] in
1851, which focused more on the 'uramische Intoxikation' and
its clinical signs than on what happened to the kidney itself. He
described the clinical uremic syndrome and dared to accept a
toxic mechanism as its etiology. His treatise is a medical
classic, though the chemical data on which it was based were
shaky: the rise of blood concentration of urea was unpredict-
able and he mistakenly considered that ammonium carbonate,
which he also found in the blood, was responsible for the toxic
effects of uremia.
In 1856 J. Picard in Strasbourg [341 developed a reproducible
and sensitive method for the measurement of blood urea. He
was able to detect the 40% fall in urea concentration occurring
between the renal artery and vein. Though the technique was
criticized by experts, such as Recklinghausen [35], it proved
itself quickly, and there was a general agreement that renal
failure was a condition accompanied uniformly by a rise in
blood urea concentration. Actually both Frerichs' monograph
and Picard's method combined to make popular the concept
and the term "uremia."
Urea, certainly, but how and what else. . ?
Although the term uremia came into general usage and blood
urea concentration was accepted as a valuable practical marker
Richet: History of uremia 1015
of renal failure, urea was still not accepted as the toxic
substance responsible for the uremic syndrome. It was obvious
to Vauquelin and Ségalas 1361 that urea itself was not acutely
toxic. Frerichs, 1331 who studied nephrectomized animals in-
jected with urea, reached a similar conclusion. Several years
later, Claude Bernard [37] revived the suggestion that uremic
toxicity was due to ammonium carbonate absorbed from the
gut. Experimental pathologists and physicians endeavored to
study the poisonous end products of protein metabolism and
attempted to relate these products to the appearance of clinical
abnormalities, particularly those involving the central nervous,
gastrointestinal, and cardiovascular systems. A special tribute
has been given to Traube [38], whose studies led eventually to
the discovery of the role of hypertension in the signs of
advanced kidney disease, even when the blood urea was not
especially elevated, and of the fluid and electrolyte disturbances
in the clinical manifestations of kidney disease. However, to
this day, the precise "uremic toxins" have not been identified.
Experimental studies still have not excluded a possible role for
chronic urea intoxication. One hundred and fifty years after its
birth, 'uremia" remains a clinico-chemical enigma.
Conclusion
The early history of uremia represents an interesting example
of the evolution of important medical concepts. In 1830 the
subject was advanced by intelligent, well-educated nosologists
trained to Ihink in structural terms. Few of them had the
personal strength to turn against their educational backgrounds.
Others who dared to pay attention to the concept of humoral
disturbances did not master the chemical approach needed to
validate their hypotheses. Both groups, however talented,
missed the birth of uremia. Those few investigators responsible
for extracting the concept of uremia from 'Terra Ingognita'
succeeded in widening their knowledge by becoming expert in
both nosology and chemical pathology. It is interesting to
ponder what sort of comparable open road nephrologists may
be missing today.
Reprint requests to Professeur Gabriel Richet, /7, rue Guéngaud,
75006 Paris, France.
References
1. BOERHAAVE H: E/cinenta Chemiac. (in Latin) Paris, G. Cavelier,
1733, Pub. 2 Vol, Vol I, p. 37 (Academic MCdecine Shelf Number
D 1367), and French Translation, Elements de Chymie. Amster-
dam, 1752, 2 Vol, Vol 1, pp. 77—78 (Ibid. Number 34542)
2. ROUELLE H: Observations sur l'urine humaine et sur celle de
Vache et de Cheval comparees ensemble. Journal de MCdecine
Chirurgie, etc., Paris Juillet, 1773, Tome XL, pp. 451—468
3. FOURCROY AF, VAUQUELIN N: MCmoire pour servir a l'histoire
naturelle chimique et médicale de l'urine humaine. Mé,noires de
/'Institut tome 2, 431 p., 4 avril 1797
4. idem tome 4, 363 p., 1799
5. FOURCROY AF, VAUQUELIN N: Nouvelles expCriences sur l'Urée.
Anna/es du Museum d'Histoire nature/Ic tome II, 226, 1808
6. BERARD JE: Essaj sur l'analyse des substances animales. Anna/es
de Chimie ci de Physique 1817. tome V. pp. 294—298 (Fac Med No
90006)
7. PROUT W: Observations on the nature of some of the proximate
principles of the urine. Medico Chirurgical Transactions (vol VIII)
1817, pp. 526—549 (Ac. Med No 93.159)
8. PEITZMAN SJ: Bright's Disease and Bright's generation—Toward
exact medicine at Guy's Hospital. Biil Hist Med 55:307—321, 1981
9. COLEY NG: George Owen Rees (1813—89) Pioneer of Medical
Chemistry Medical History 30:173—190, 1986
10. PREVOST JL, DUMAS JB: SociCté de Physiologic et d'Histoire
Naturelle de Genève. 15.11.1821, in Anna/es de Chimie etPhysique
Paris XX!!! p. 90, 1823
lI. WOOHLER F: Uber kdnstlische Bildung des Harnstoffs. Anna/en
des Physic u,id Chemie, tome 12, 253, 1828. French translation in
Ann Chimie ci Physique, 1828, tome 37, pp. 330—334.
12. BEd-lAMP M: Sur les substances albuminoldes et leur transforma-
tion en urée. Anna/es de Chi,nie ci de Physique, 1856, 3ëme Série
Tome XLVIII, pp. 348—355
13. DUTROCHET RJH: Nouvelles observations sur l'endosmose et sur
l'exosmose et sur Ia cause de cc double phénomène. Anna/es de
Physique ci de Chimie XXXV:393, 1827
14. NY5TEN PH: Recherches de Physiologic ci de Chi,nie Patholo-
giques. Paris, 1811, Quoted by P. Rayer 1, p. 58—59
15. PROUT W: Inquiry on the nature and treatment of gravel, calculus
and other diseases connected with deranged operation of urinary
organs. I Vol. London 1821, and 2nd ed, 1825
16. BRIGHT R: Original papers on renal diseases, edited by OSMAN AA
London. Oxford University Press, 1937
17. BOSTOCK J: Letter to Bright 1827, in Original papers on Renal
Diseases, edited by OSMAN AA, Oxford University Press, London,
1937
18. BARLOW GH: Quoted by Bright see 16.
19. REES GO: On the presence of urea in the blood. London Med
Gazette 1833, pp. 676, 703, 765, 863
20. CHRIs'rlsoN R: Observations on the variety of dropsy which
depends of diseased kidneys. Edinburgh MedSurg J tome 32: 263,
Oct 1829
21. GREGORY JC: On diseased states of the kidney connected in life
with albuminous urine. Edinhurg Med Surg J part 1, 36:315—363,
1831 part 11, 37:54—94, 1832
22. RAYER P: Traité des Maladies des Reins. BailliCre, Paris, London,
3 Vol, 1837, 1843
23. MARCI-IAND RF: Lehrhuch des physiologischcn Chemie 1844
24. CI-IRISTIsON R: On the granular degeneration of the kidneys. I Vol.
North Bridge, Edinburgh, Adam and Charles Black, 1839
25. WILsoN A: On fits and sudden death in connexion with diseases of
the kidneys. London Med Gazette XI: 777, 1832
26. ADDIsON Tn: On the disorders of the brain connected with dis-
eased kidneys. Guy's Hospital Reports 1839, pp. 1—9
27. BURROWS G: Physiological and pathological observations on the
blood and urine. London Med Gazette XIV: 502—552, 585—633, 1834
28. ACKERKNECHT EH: Medicine at the Paris Hospital 1794—1848.
Baltimore, The Johns Hopkins Press, 1966, 242 pages
29. ANDRAL G: E.csai d'Hemato/ogie Pathologique. Paris, Fortin Ed,
1844, 186 pages
30. PIORRY PA, IN PIORRY PA, L'HERITIER D: Traité des Alterations
do Sang, Chapter XIl. Paris, Baillière Ed, 1840
31. PIORRY PA: TraitC de MCdecine Pratique tome III, Chapter XII. No
4430 to 4440, Paris, BailliCre Ed, 1847
32. BECQUEREL A. RODIER: TraitC de Chi,nie Paihologique app/iquee
h Ia MCdecine Pratique Paris Germer Baillière 1854, 608 p
33. FRERICI-IS FT: Die Brighr'.s'chc Nicrcnkrankheit and deren Bc/sand-
lung. Braunschweig, Eine Monographie, 1851, 286 p
34. PICARD J: Dc /a presence de l'urée duns Ic sang. These, Stras-
bourg, 96 p, 1856 (available at Academic Nationale de Médecine.
Paris; shelf mark 10708)
35. RECKLINGI-IAUSEN: uber Picard's Bestimmung's Methode des Ham-
stoffs im Blut. Virchow Arc'hiv XIV: 476, 1858
36. VAUQUELIN N, SEGALAS: Journal de P/sysio/ogie II: 354,
182 1—1 822
37. BERNARD C: Les liquides c/c l'organisme. Vol II, Paris, BailliCre,
1859, pp. 24T52
38. TRAUBE L: Uber den Zusammenhang von Herz und Nierenkran-
kheiten. I Vol. Berlin, August Hirschwald, 1856
